Big Pharma, Bigger Bargain: Why Merck Stock Is Too Cheap To Ignore (Upgrade)

Join iREIT on Alpha today to get the most in-depth research that includes REITs, mREITs, Preferreds, BDCs, MLPs, ETFs, and other income alternatives. 438 testimonials and most are 5 stars. Nothing to lose with our FREE 2-week trial .I'm not breaking any news when I say that healthcare costs are becoming an issue. I believe we all have felt this through rising healthcare premiums and other ways.Analyst’s Disclosure: I/we have a beneficial long position in the shares of ABBV either through stock ownership, op ...